Melanoma and other malignant neoplasms of skin
Showing 1 - 25 of >10,000
Monitoring T Cell Responses in Melanoma, Lung and Other Cancer
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +9 more
- Biospecimen Collection
- Electronic Health Record Review
-
Rochester, MinnesotaMayo Clinic in Rochester
Oct 4, 2023
Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (Azacitidine, Pembrolizumab)
Active, not recruiting
- Melanoma and Other Malignant Neoplasms of Skin
- Metastatic Melanoma
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 31, 2022
Malignant Tumor of Bone and Articular Cartilage, Malignant Tumors of Female Genital Organs, Malignant Tumors of Independent
Recruiting
- Malignant Neoplasm of Bone and Articular Cartilage
- +9 more
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Oct 26, 2022
Using Non-invasive Methods to Investigate Mutation Burden in
Not yet recruiting
- Melanoma and Other Malignant Neoplasms of Skin
- Observational Study Only
-
Pittsburgh, PennsylvaniaUPMC
Oct 27, 2022
Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (GSK2636771, Pembrolizumab)
Active, not recruiting
- Melanoma and Other Malignant Neoplasms of Skin
- Metastatic Melanoma
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 22, 2022
Melanoma and Other Malignant Tumors of Skin Trial in New Brunswick (UV4.me2, UV4.me, E-Pamphlet)
Completed
- Melanoma and Other Malignant Neoplasms of Skin
- UV4.me2
- +2 more
-
New Brunswick, New Jersey
- +1 more
Sep 27, 2022
BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Malignant Solid Tumor Trial in Boston (Dabrafenib,
Active, not recruiting
- BRAF V600E Mutation Present
- +9 more
- Dabrafenib
- +4 more
-
Boston, Massachusetts
- +1 more
Jun 28, 2022
Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)
Completed
- Stage III Malignant Melanoma of Skin AJCC V6
- Stage IV Malignant Melanoma of Skin
- TAPCells vaccine
-
Santiago, RM, ChileFaculty of Medicine, University of Chile
Nov 21, 2023
Melanoma, Melanoma (Skin), Moles Trial in Nizhny Novgorod, Moscow (Non-invasive adhesive system (patch))
Recruiting
- Melanoma
- +11 more
- Non-invasive adhesive system (patch)
-
Nizhny Novgorod, Russian Federation
- +1 more
Jun 12, 2022
Solid Tumor, Breast Cancer, Small Cell and NSCLC Trial in Hackensack (RAPA-201 Rapamycin Resistant T Cells, Chemotherapy Prior
Recruiting
- Solid Tumor
- +15 more
- RAPA-201 Rapamycin Resistant T Cells
- Chemotherapy Prior to RAPA-201 Therapy
-
Hackensack, New JerseyHackensack University Medical Center
Dec 23, 2021
Melanoma (Skin), Nevus, Nevus, Spitz Trial in Moscow, Nizhny Novgorod (Mobile phone application "ProRodinki")
Recruiting
- Melanoma (Skin)
- +9 more
- Mobile phone application "ProRodinki"
-
Moscow, Russian Federation
- +1 more
May 29, 2022
EVALUATING THE CURRENT STANDARD OF CARE FOR PATIENTS DIAGNOSED
Not yet recruiting
- Melanoma (Skin)
- Melanoma
- (no location specified)
Jun 2, 2023
Cutaneous Malignant Melanoma Trial in Belgium, Hungary (Vitamin D, arachides oleum raffinatum)
Active, not recruiting
- Cutaneous Malignant Melanoma
- Vitamin D
- arachides oleum raffinatum
-
Edegem, Belgium
- +3 more
May 18, 2022
Melanoma, Skin Cancer Trial in Copenhagen (DermLoop Learn)
Enrolling by invitation
- Melanoma
- Skin Cancer
- DermLoop Learn
-
Copenhagen, Denmark
- +1 more
Dec 5, 2022
Melanoma (Skin), Carcinoma Trial in Copenhagen (Dermloop Learn)
Completed
- Melanoma (Skin)
- Carcinoma
- Dermloop Learn
-
Copenhagen, Danmark, DenmarkAISC Research Fascility
Dec 13, 2022
Skin Cancer, Melanoma, Malignant Skin Tumor Trial in Portland (device, procedure, other)
Not yet recruiting
- Skin Cancer
- +2 more
- Skin Examination
- Survey Administration
-
Portland, OregonOHSU Knight Cancer Institute
Nov 3, 2022
Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin, Merkel Cell Carcinoma of Skin Trial in Marlborough (PH-762)
Not yet recruiting
- Squamous Cell Carcinoma of the Skin
- +2 more
-
Marlborough, MassachusettsPhio Pharmaceuticals Corp.
Aug 25, 2023
Malignant Melanoma, Merkel Cell Carcinoma Trial in Bern (Visionsenseā¢ VS3 - Stereoscopic High Definition Visualisation System
Completed
- Malignant Melanoma
- Merkel Cell Carcinoma
- Visionsenseā¢ VS3 - Stereoscopic High Definition Visualisation System (VS3-3DHD)
-
Bern, Kanton Bern, SwitzerlandInselspital, University Hospital Bern, University of Bern
Dec 7, 2022
NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)
Not yet recruiting
- Non-small Cell Lung Cancer
- +32 more
- (no location specified)
Mar 30, 2023
Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States
Recruiting
- Adenoid Cystic Skin Carcinoma
- +38 more
- Biopsy
- +6 more
-
Los Angeles, California
- +35 more
Jan 31, 2023
Skin Cancer, Malignant Melanoma Trial in Copenhagen (Reflectance confocal microscopy (RCM), Photoacoustic imaging (PAI) and
Recruiting
- Skin Cancer
- Malignant Melanoma
- Reflectance confocal microscopy (RCM), Photoacoustic imaging (PAI) and tape-strippng of RNA and lipids
-
Copenhagen, DenmarkDept of Dermatology
May 20, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Los Angeles
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Magnetic Resonance Imaging using 7 Tesla MRI
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 12, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Malignant Solid Tumor Trial in
Active, not recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +4 more
- Dabrafenib
- +4 more
-
Phoenix, Arizona
- +48 more
Jan 3, 2023
Metastatic Malignant Tumor in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in Houston (drug,
Active, not recruiting
- Metastatic Malignant Neoplasm in the Brain
- +7 more
- Binimetinib
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jun 15, 2022